Skip to main content
Top
Gepubliceerd in: Neuropraxis 2/2016

09-03-2016 | Artikel

Stress en veerkracht: de rol van de mineralocorticoïd receptor

Auteurs: Christiaan H. Vinkers, Freija ter Heegde, Roel H. de Rijk

Gepubliceerd in: Neuropraxis | Uitgave 2/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Corticosteroïden die afgegeven worden tijdens stress binden aan twee receptoren in de hersenen: de mineralocorticoïd receptor (MR) en de glucocorticoïd receptor (GR). Hoewel de MR minder bekend is dan de GR, hebben baanbrekende studies in de afgelopen jaren aangetoond dat de MR essentieel is voor optimale adaptatie tijdens stress en het houden van veerkracht. (Pre)klinische studies suggereren dat de MR niet alleen de basale en stressgeïnduceerde HPA-as-activiteit beïnvloedt, maar ook hoe een stressvolle situatie wordt ingeschat en onthouden. Deze effecten worden gemedieerd door zowel de genomische als de niet-genomische MR en zijn ten minste gedeeltelijk geslachtsafhankelijk. Met name na blootstelling aan stress lijkt een hoge activiteit van de MR veerkracht te bevorderen. Dit betekent dat personen met een relatief lage MR-functionaliteit een verhoogde gevoeligheid voor stressgerelateerde depressieve klachten hebben. Daarnaast kan meer MR-activiteit een stressgerelateerde depressie voorkómen of omkeren. Ondanks het beperkte aantal klinische studies laten de bestaande studies zien dat de MR een belangrijke veerkrachtfactor vormt en een rol kan spelen bij de preventie en behandeling van stressgerelateerde psychiatrische stoornissen.
Literatuur
1.
go back to reference Kloet ER de, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463–75.CrossRefPubMed Kloet ER de, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463–75.CrossRefPubMed
2.
go back to reference McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004;1032:1–7.CrossRefPubMed McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004;1032:1–7.CrossRefPubMed
3.
go back to reference Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35(1):2–16.CrossRefPubMed Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35(1):2–16.CrossRefPubMed
4.
go back to reference Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 2008;33(6):693–710.CrossRefPubMed Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 2008;33(6):693–710.CrossRefPubMed
5.
go back to reference Kloet ER de. Functional profile of the binary brain corticosteroid receptor system: mediating, multitasking, coordinating, integrating. Eur J Pharmacol. 2013;719(1–3):53–62.CrossRefPubMed Kloet ER de. Functional profile of the binary brain corticosteroid receptor system: mediating, multitasking, coordinating, integrating. Eur J Pharmacol. 2013;719(1–3):53–62.CrossRefPubMed
6.
go back to reference Harris AP, Holmes MC, Kloet ER de, Chapman KE, Seckl JR. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology. 2013;38(5):648–58.CrossRefPubMed Harris AP, Holmes MC, Kloet ER de, Chapman KE, Seckl JR. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology. 2013;38(5):648–58.CrossRefPubMed
8.
go back to reference Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res. 2000;34(6):383–92.CrossRefPubMed Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res. 2000;34(6):383–92.CrossRefPubMed
9.
go back to reference Seckl JR, Dickson KL, Yates C, Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 1991;561(2):332–7.CrossRefPubMed Seckl JR, Dickson KL, Yates C, Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 1991;561(2):332–7.CrossRefPubMed
10.
go back to reference Reul JM, Kloet ER de. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117(6):2505–11.CrossRefPubMed Reul JM, Kloet ER de. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985;117(6):2505–11.CrossRefPubMed
11.
go back to reference Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, et al. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004;151(3):397–406.CrossRefPubMed Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, et al. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol. 2004;151(3):397–406.CrossRefPubMed
12.
go back to reference Rupprecht R, Reul JM, Steensel B van, Spengler D, Soder M, Berning B, et al. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 1993;247(2):145–54.CrossRefPubMed Rupprecht R, Reul JM, Steensel B van, Spengler D, Soder M, Berning B, et al. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur J Pharmacol. 1993;247(2):145–54.CrossRefPubMed
13.
go back to reference De Kloet ER, Reul JM. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology. 1987;12(2):83–105.CrossRefPubMed De Kloet ER, Reul JM. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology. 1987;12(2):83–105.CrossRefPubMed
14.
go back to reference Joels M, Sarabdjitsingh RA, Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol Rev. 2012;64(4):901–38.CrossRefPubMed Joels M, Sarabdjitsingh RA, Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol Rev. 2012;64(4):901–38.CrossRefPubMed
15.
go back to reference Karst H, Berger S, Erdmann G, Schutz G, Joels M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A. 2010;107(32):14449–54.CrossRefPubMedPubMedCentral Karst H, Berger S, Erdmann G, Schutz G, Joels M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A. 2010;107(32):14449–54.CrossRefPubMedPubMedCentral
16.
go back to reference Vinkers CH, Joels M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, et al. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 2015;54:90–102.CrossRefPubMed Vinkers CH, Joels M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, et al. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 2015;54:90–102.CrossRefPubMed
17.
go back to reference Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol. 2005;19(9):2211–21.CrossRefPubMed Pascual-Le Tallec L, Lombes M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol Endocrinol. 2005;19(9):2211–21.CrossRefPubMed
18.
go back to reference Groeneweg FL, Karst H, Kloet ER de, Joels M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol. 2012;350(2):299–309.CrossRefPubMed Groeneweg FL, Karst H, Kloet ER de, Joels M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol. 2012;350(2):299–309.CrossRefPubMed
19.
go back to reference Joels M, Karst H, DeRijk R, Kloet ER de. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008;31(1):1–7.CrossRefPubMed Joels M, Karst H, DeRijk R, Kloet ER de. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008;31(1):1–7.CrossRefPubMed
20.
go back to reference Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, et al. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci U S A. 2006;103(1):195–200.CrossRefPubMedPubMedCentral Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, et al. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci U S A. 2006;103(1):195–200.CrossRefPubMedPubMedCentral
21.
go back to reference Munier M, Law F, Meduri G, Le Menuet D, Lombes M. Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Endocrinology. 2012;153(3):1330–40.CrossRefPubMedPubMedCentral Munier M, Law F, Meduri G, Le Menuet D, Lombes M. Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Endocrinology. 2012;153(3):1330–40.CrossRefPubMedPubMedCentral
22.
go back to reference Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1988;1(9):887–900.CrossRefPubMed Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron. 1988;1(9):887–900.CrossRefPubMed
23.
go back to reference Pascual-Le Tallec L, Demange C, Lombes M. Human mineralocorticoid receptor A and B protein forms produced by alternative translation sites display different transcriptional activities. Eur J Endocrinol. 2004;150(4):585–90.CrossRefPubMed Pascual-Le Tallec L, Demange C, Lombes M. Human mineralocorticoid receptor A and B protein forms produced by alternative translation sites display different transcriptional activities. Eur J Endocrinol. 2004;150(4):585–90.CrossRefPubMed
24.
go back to reference Leeuwen N van, Kumsta R, Entringer S, Kloet ER de, Zitman FG, DeRijk RH, et al. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology. 2010;35(3):339–49.CrossRefPubMed Leeuwen N van, Kumsta R, Entringer S, Kloet ER de, Zitman FG, DeRijk RH, et al. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology. 2010;35(3):339–49.CrossRefPubMed
25.
go back to reference Ferrari P. The role of 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Biochim Biophys Acta. 2010;1802(12):1178–87.CrossRefPubMed Ferrari P. The role of 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Biochim Biophys Acta. 2010;1802(12):1178–87.CrossRefPubMed
26.
go back to reference Klok MD, Giltay EJ, Van der Does AJ, Geleijnse JM, Antypa N, Penninx BW, et al. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry. 2011;1:e62.CrossRefPubMedPubMedCentral Klok MD, Giltay EJ, Van der Does AJ, Geleijnse JM, Antypa N, Penninx BW, et al. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl Psychiatry. 2011;1:e62.CrossRefPubMedPubMedCentral
27.
go back to reference Klok MD, Alt SR, Irurzun Lafitte AJ, Turner JD, Lakke EA, Huitinga I, et al. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiatr Res. 2011;45(7):871–8.CrossRefPubMed Klok MD, Alt SR, Irurzun Lafitte AJ, Turner JD, Lakke EA, Huitinga I, et al. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiatr Res. 2011;45(7):871–8.CrossRefPubMed
28.
go back to reference Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W, Jr., Myers RM, et al. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J Psychiatr Res. 2013;47(3):307–14.CrossRefPubMedPubMedCentral Medina A, Seasholtz AF, Sharma V, Burke S, Bunney W, Jr., Myers RM, et al. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J Psychiatr Res. 2013;47(3):307–14.CrossRefPubMedPubMedCentral
29.
go back to reference Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab. 1998;83(9):3339–45.PubMed Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab. 1998;83(9):3339–45.PubMed
30.
go back to reference Bjartmar L, Johansson IM, Marcusson J, Ross SB, Seckl JR, Olsson T. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl). 2000;151(1):7–12.CrossRef Bjartmar L, Johansson IM, Marcusson J, Ross SB, Seckl JR, Olsson T. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl). 2000;151(1):7–12.CrossRef
31.
go back to reference Lopez JF, Chalmers DT, Little KY, Watson SJ. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry. 1998;43(8):547–73.CrossRefPubMed Lopez JF, Chalmers DT, Little KY, Watson SJ. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry. 1998;43(8):547–73.CrossRefPubMed
32.
go back to reference Reul JM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 1994;60(5):509–19.CrossRefPubMed Reul JM, Labeur MS, Grigoriadis DE, De Souza EB, Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 1994;60(5):509–19.CrossRefPubMed
33.
go back to reference Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 1992;55(6):621–6.CrossRefPubMed Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 1992;55(6):621–6.CrossRefPubMed
34.
go back to reference Yau JL, Olsson T, Morris RG, Meaney MJ, Seckl JR. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience. 1995;66(3):571–81.CrossRefPubMed Yau JL, Olsson T, Morris RG, Meaney MJ, Seckl JR. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience. 1995;66(3):571–81.CrossRefPubMed
35.
go back to reference Xing, G.-Q., Russell, S., Webster, M.J., Post, R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol. 2004;7:143–53.CrossRefPubMed Xing, G.-Q., Russell, S., Webster, M.J., Post, R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol. 2004;7:143–53.CrossRefPubMed
36.
go back to reference Qi, X.-R., Kamphuis, W., Wang, S., Wang, Q., Lucassen, P.J., Zhou, J.-N., Swaab, D.F. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology. 2013;38:863–70.CrossRefPubMed Qi, X.-R., Kamphuis, W., Wang, S., Wang, Q., Lucassen, P.J., Zhou, J.-N., Swaab, D.F. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology. 2013;38:863–70.CrossRefPubMed
37.
go back to reference Wang, S.-S., Kamphuis, W., Huitinga, I., Zhou, J.-N., Swaab, D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry. 2008;13:786–99, 741.CrossRefPubMed Wang, S.-S., Kamphuis, W., Huitinga, I., Zhou, J.-N., Swaab, D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry. 2008;13:786–99, 741.CrossRefPubMed
38.
go back to reference Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A, et al. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology. 2015;40(2):386–93.CrossRefPubMedPubMedCentral Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A, et al. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology. 2015;40(2):386–93.CrossRefPubMedPubMedCentral
39.
go back to reference Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K, et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res. 2010;44(6):339–46.CrossRefPubMed Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K, et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res. 2010;44(6):339–46.CrossRefPubMed
40.
go back to reference Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res. 1999;33(3):181–214.CrossRefPubMed Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res. 1999;33(3):181–214.CrossRefPubMed
41.
go back to reference Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry. 2004;61(12):1235–44.CrossRefPubMed Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry. 2004;61(12):1235–44.CrossRefPubMed
42.
go back to reference Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ. The role of mineralocorticoid receptor function in treatment-resistant depression. J Psychopharmacol. 2013;27(12):1169–79.CrossRefPubMed Juruena MF, Pariante CM, Papadopoulos AS, Poon L, Lightman S, Cleare AJ. The role of mineralocorticoid receptor function in treatment-resistant depression. J Psychopharmacol. 2013;27(12):1169–79.CrossRefPubMed
43.
go back to reference Hlavacova N, Jezova D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav. 2008;54(1):90–7.CrossRefPubMed Hlavacova N, Jezova D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav. 2008;54(1):90–7.CrossRefPubMed
44.
go back to reference Hlavacova N, Wes PD, Ondrejcakova M, Flynn ME, Poundstone PK, Babic S, et al. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int J Neuropsychopharmacol. 2012;15(2):247–65.CrossRefPubMed Hlavacova N, Wes PD, Ondrejcakova M, Flynn ME, Poundstone PK, Babic S, et al. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int J Neuropsychopharmacol. 2012;15(2):247–65.CrossRefPubMed
45.
go back to reference Murck H, Schussler P, Steiger A. Renin-angiotensin-aldosterone system: the forgotten stress hormone system: relationship to depression and sleep. Pharmacopsychiatry. 2012;45(3):83–95.CrossRefPubMed Murck H, Schussler P, Steiger A. Renin-angiotensin-aldosterone system: the forgotten stress hormone system: relationship to depression and sleep. Pharmacopsychiatry. 2012;45(3):83–95.CrossRefPubMed
46.
go back to reference Rafatian N, Westcott KV, White RA, Leenen FH. Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade. Am J Physiol Regul Integr Comp Physiol. 2014;307(7):R879–87.CrossRefPubMed Rafatian N, Westcott KV, White RA, Leenen FH. Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade. Am J Physiol Regul Integr Comp Physiol. 2014;307(7):R879–87.CrossRefPubMed
47.
go back to reference Carey MP, Deterd CH, Koning J de, Helmerhorst F, Kloet ER de. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol. 1995;144(2):311–21.CrossRefPubMed Carey MP, Deterd CH, Koning J de, Helmerhorst F, Kloet ER de. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol. 1995;144(2):311–21.CrossRefPubMed
48.
go back to reference Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, et al. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol. 2002;146(6):789–99.CrossRefPubMed Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, et al. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol. 2002;146(6):789–99.CrossRefPubMed
49.
go back to reference Turner BB. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci. 1990;46(19):1399–406.CrossRefPubMed Turner BB. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci. 1990;46(19):1399–406.CrossRefPubMed
50.
go back to reference Castren M, Patchev VK, Almeida OF, Holsboer F, Trapp T, Castren E. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology. 1995;136(9):3800–6.PubMed Castren M, Patchev VK, Almeida OF, Holsboer F, Trapp T, Castren E. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology. 1995;136(9):3800–6.PubMed
51.
go back to reference Heegde F ter, De Rijk RH, Vinkers CH. The brain mineralocorticoid receptor and stress resilience. Psychoneuroendocrinology. 2015;52:92–110.CrossRefPubMed Heegde F ter, De Rijk RH, Vinkers CH. The brain mineralocorticoid receptor and stress resilience. Psychoneuroendocrinology. 2015;52:92–110.CrossRefPubMed
52.
go back to reference Klok MD, Vreeburg SA, Penninx BW, Zitman FG, Kloet ER de, DeRijk RH. Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: interaction with SSRIs. Psychoneuroendocrinology. 2011;36(4):484–94.CrossRefPubMed Klok MD, Vreeburg SA, Penninx BW, Zitman FG, Kloet ER de, DeRijk RH. Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: interaction with SSRIs. Psychoneuroendocrinology. 2011;36(4):484–94.CrossRefPubMed
53.
go back to reference Watzka M, Beyenburg S, Blumcke I, Elger CE, Bidlingmaier F, Stoffel-Wagner B. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neurosci Lett. 2000;290(2):121–4.CrossRefPubMed Watzka M, Beyenburg S, Blumcke I, Elger CE, Bidlingmaier F, Stoffel-Wagner B. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neurosci Lett. 2000;290(2):121–4.CrossRefPubMed
54.
go back to reference Kellner M, Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur J Pharmacol. 2008;583(2–3):372–8.CrossRefPubMed Kellner M, Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur J Pharmacol. 2008;583(2–3):372–8.CrossRefPubMed
Metagegevens
Titel
Stress en veerkracht: de rol van de mineralocorticoïd receptor
Auteurs
Christiaan H. Vinkers
Freija ter Heegde
Roel H. de Rijk
Publicatiedatum
09-03-2016
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 2/2016
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/s12474-016-0116-5

Andere artikelen Uitgave 2/2016

Neuropraxis 2/2016 Naar de uitgave